We demonstrated that miR-148a could regulate the expression of ACVR1 by directly targeting the 3′ UTR of its mRNA and modulate the BMP signaling pathway, which suggest that miR-148a could be used as a new target for the development of therapeutic agents against FOP. This evidence concerns the gene ACVR1 and fibrodysplasia ossificans progressiva.